Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
or

Evolus Inc (EOLS)

Evolus Inc (EOLS)
11.05 x 5 11.39 x 5
Post-market by (Cboe BZX)
11.23 +0.77 (+7.36%) 04/23/25 [NASDAQ]
11.05 x 5 11.39 x 5
Post-market 11.23 unch (unch) 17:42 ET
Quote Overview for Wed, Apr 23rd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
10.71
Day High
11.36
Open 10.79
Previous Close 10.46 10.46
Volume 1,074,500 1,074,500
Avg Vol 1,032,640 1,032,640
Stochastic %K 56.01% 56.01%
Weighted Alpha -23.34 -23.34
5-Day Change +1.00 (+9.78%) +1.00 (+9.78%)
52-Week Range 8.67 - 17.82 8.67 - 17.82
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 665,120
  • Shares Outstanding, K 63,587
  • Annual Sales, $ 266,270 K
  • Annual Income, $ -50,420 K
  • EBIT $ -32 M
  • EBITDA $ -25 M
  • 60-Month Beta 0.97
  • Price/Sales 2.48
  • Price/Cash Flow N/A
  • Price/Book 119.03

Options Overview Details

View History
  • Implied Volatility 84.27% ( +13.04%)
  • Historical Volatility 73.56%
  • IV Percentile 89%
  • IV Rank 50.28%
  • IV High 149.64% on 04/10/25
  • IV Low 18.15% on 05/21/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 526
  • Volume Avg (30-Day) 219
  • Put/Call OI Ratio 0.05
  • Today's Open Interest 4,149
  • Open Int (30-Day) 4,750

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.18
  • Number of Estimates 1
  • High Estimate -0.18
  • Low Estimate -0.18
  • Prior Year -0.20
  • Growth Rate Est. (year over year) +10.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.67 +29.53%
on 04/09/25
Period Open: 13.03
13.18 -14.80%
on 03/24/25
-1.80 (-13.81%)
since 03/21/25
3-Month
8.67 +29.53%
on 04/09/25
Period Open: 14.02
17.12 -34.40%
on 02/13/25
-2.79 (-19.90%)
since 01/23/25
52-Week
8.67 +29.53%
on 04/09/25
Period Open: 11.70
17.82 -36.98%
on 10/14/24
-0.47 (-4.02%)
since 04/23/24

Most Recent Stories

More News
Mixue Group's Splashy Debut, Kroger's Change, Stuffed Crust Pizza, and Med Spas

There's a lot going on for investors.

EOLS : 11.23 (+7.36%)
SBUX : 82.81 (+1.30%)
PZZA : 32.74 (+3.64%)
KR : 72.00 (-1.34%)
ACI : 22.41 (-0.49%)
ABBV : 177.05 (+1.88%)
DPZ : 485.88 (-0.05%)
MCD : 318.48 (-0.19%)
Why Shares of Evolus Are Jumping Thursday

The stock climbed on record second-quarter revenue and a raise in full-year guidance.

EOLS : 11.23 (+7.36%)
Twitter Faces Threats From AI and Threads

AI is changing the open internet landscape, and Meta's new Threads app is looking to take a bite out of Twitter's audience.

META : 520.27 (+4.00%)
GOOGL : 155.35 (+2.56%)
GOOG : 157.72 (+2.48%)
EOLS : 11.23 (+7.36%)
MODG : 6.60 (+0.61%)
GOLF : 61.94 (+0.47%)
TWTR : 53.70 (+0.66%)
ADBE : 351.96 (+0.59%)
PM : 168.11 (+2.44%)
DIS : 87.29 (+1.39%)
WMT : 94.96 (+0.12%)
Evolus to Report First Quarter 2023 Results and Provide Business Update

Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that it will report its first quarter 2023 financial...

EOLS : 11.23 (+7.36%)
Evolus Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update

Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today reported financial results for the fourth quarter and full...

EOLS : 11.23 (+7.36%)
Evolus to Participate in the Barclays Global Healthcare Conference

Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that members of its management team will be participating...

EOLS : 11.23 (+7.36%)
Evolus Initiates Nuceiva® Launch in Germany and Austria

Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, has commenced the commercial launch of Nuceiva ® (botulinum toxin...

EOLS : 11.23 (+7.36%)
Evolus to Report Fourth Quarter and Year End 2022 Results and Provide Business Update

Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that it will report its fourth quarter and year end...

EOLS : 11.23 (+7.36%)
Evolus Not Affected by Recent Korean Court Ruling

Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, issued the following statement.

EOLS : 11.23 (+7.36%)
Evolus to Participate in the SVB Securities Global Biopharma Conference

Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that members of its management team will be participating...

EOLS : 11.23 (+7.36%)

Business Summary

Evolus, Inc. is a medical aesthetics company. It focuses on providing physicians and patients in aesthetic procedures and treatments. The company focuses on the self-pay aesthetic market and its lead product candidate, DWP-450, is an injectable 900 kDa purified botulinum toxin type A complex. Evolus,...

See More

Key Turning Points

3rd Resistance Point 12.14
2nd Resistance Point 11.75
1st Resistance Point 11.49
Last Price 11.23
1st Support Level 10.84
2nd Support Level 10.45
3rd Support Level 10.19

See More

52-Week High 17.82
Fibonacci 61.8% 14.32
Fibonacci 50% 13.24
Fibonacci 38.2% 12.17
Last Price 11.23
52-Week Low 8.67

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective